Antiphospholipid antibodies.
This review has focused on some recent developments which have begun to define the immunologic specificity of aPL antibodies. These studies have revealed that these immunoglobulins are more complex than has been realised to date and, more importantly, they offer new approaches to investigate how the prothrombotic diathesis associated with aPL antibodies might arise.
McNeil
H P
HP
Department of Rheumatology and Immunology, Brigham and Women's Hospital, Boston, Massachusetts.
Krilis
S A
SA
D016736:Antiphospholipid Syndrome / Q000276:immunology / Q000628:therapy; D001323:Autoantibodies / Q000032:analysis / Q000276:immunology; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D010743:Phospholipids / Q000276:immunology*
D001323:Autoantibodies; D010743:Phospholipids